The Europe Inhaled Nitric Oxide Market would witness market growth of 7.4% CAGR during the forecast period (2020-2026). Nitric oxide is a gas form of the chemical molecule, which is utilized to cure newborn babies with serious breathing problems related to narrow blood vessels in the lungs.
It helps in relaxing the muscle while broadening (dilate) blood vessels in the lungs. Nitric oxide is majorly utilized along with a breathing machine like a ventilator. The increasing prevalence of respiratory diseases and the continuing research & development activities regarding the usage of inhaled nitric oxide are among the factors that will drive the growth of the Inhaled nitric oxide market.
There are many studies that suggested that Nitric Oxide can be applied to various diseases. For example, studies stated that inhaled NO is a secure and efficient agent to identify the vasodilatory capability of the pulmonary vascular bed. At present, many incidents also suggest that inhaled nitric oxide enhances oxygenation & reduces the integrated results of death or needs for extracorporeal membrane oxygenation in newborn babies of more than 35 weeks’ gestational age at birth. Due to the aforementioned factors, the market is estimated to witness a significant growth rate during the forecast period.
The global inhaled nitric oxide market is expected to increase over the forecast period due to the increasing prevalence of respiratory diseases, the increasing number of breathing problems in infants, and the initiatives by the FDA to motivate clinical use of inhaled nitric oxide. Additionally, technological improvements in inhaled nitric oxide and the latest product introduced by the companies operating in the market are anticipated to offer lucrative opportunities over the forecast period.
Based on Application, the market is segmented into Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS) and Other Applications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The Germany market dominated the Europe Acute Respiratory Distress Syndrome (ARDS) Market by Country in 2019, growing at a CAGR of 7.9 % during the forecast period. The UK market is exhibiting a CAGR of 7.6% during (2020 - 2026). Additionally, The France market is poised to grow at a CAGR of 10% during (2020 - 2026).
Free Valuable Insights: Inhaled Nitric Oxide Market in Europe is expected to register a CAGR of 7.4% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Getinge AB, Merck Group, Halma PLC, Linde PLC (Praxair, Inc.), Air Liquide S.A., Beyond Air, Inc., Mallinckrodt PLC (International Minerals and Chemical Corporation), VERO Biotech LLC, Nu-Med Plus, Inc. and Novoteris, LLC.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Neonatal Respiratory Treatment
- Chronic Obstructive Pulmonary Disease (COPD)
- Acute Respiratory Distress Syndrome (ARDS)
- Other Applications
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Getinge AB
- Merck Group
- Halma PLC
- Linde PLC (Praxair, Inc.)
- Air Liquide S.A.
- Beyond Air, Inc.
- Mallinckrodt PLC (International Minerals and Chemical Corporation)
- VERO Biotech LLC
- Nu-Med Plus, Inc.
- Novoteris, LLC
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Inhaled Nitric Oxide Market, by Application
1.4.2 Europe Inhaled Nitric Oxide Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Inhaled Nitric Oxide Market
Chapter 4. Europe Inhaled Nitric Oxide Market by Application
4.1 Europe Neonatal Respiratory Treatment Repellent Market by Country
4.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country
4.3 Europe Acute Respiratory Distress Syndrome (ARDS) Market by Country
4.4 Europe Other Applications Market by Country
Chapter 5. Europe Inhaled Nitric Oxide Market by Country
5.1 Germany Inhaled Nitric Oxide Market
5.1.1 Germany Inhaled Nitric Oxide Market by Application
5.2 UK Inhaled Nitric Oxide Market
5.2.1 UK Inhaled Nitric Oxide Market by Application
5.3 France Inhaled Nitric Oxide Market
5.3.1 France Inhaled Nitric Oxide Market by Application
5.4 Russia Inhaled Nitric Oxide Market
5.4.1 Russia Inhaled Nitric Oxide Market by Application
5.5 Spain Inhaled Nitric Oxide Market
5.5.1 Spain Inhaled Nitric Oxide Market by Application
5.6 Italy Inhaled Nitric Oxide Market
5.6.1 Italy Inhaled Nitric Oxide Market by Application
5.7 Rest of Europe Inhaled Nitric Oxide Market
5.7.1 Rest of Europe Inhaled Nitric Oxide Market by Application
Chapter 6. Company Profiles
6.1 Getinge AB
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expense
6.2 Merck Group
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Halma PLC
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Linde PLC (Praxair, Inc.)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Acquisition and Mergers:
6.5 Air Liquide S.A.
6.5.1 Company Overview
6.5.1 Financial Analysis
6.6 Beyond Air, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Research & Development Expense
6.6.4 Recent strategies and developments:
6.6.4.1 Trials and Approvals:
6.7 Mallinckrodt PLC (International Minerals and Chemical Corporation)
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Trials and Approvals:
6.7.5.2 Partnerships, Collaborations, and Agreements:
6.8 VERO Biotech LLC
6.8.1 Company Overview
6.8.2 Recent strategies and developments:
6.8.2.1 Trials and Approvals:
6.9 Nu-Med Plus, Inc.
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.10. Novoteris, LLC
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Trials and Approvals:
TABLE 1 Europe Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 2 Europe Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 3 Europe Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 4 Europe Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 5 Europe Neonatal Respiratory Treatment Repellent Market by Country, 2016 - 2019, USD Million
TABLE 6 Europe Neonatal Respiratory Treatment Repellent Market by Country, 2020 - 2026, USD Million
TABLE 7 Europe Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2016 - 2019, USD Million
TABLE 8 Europe Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2020 - 2026, USD Million
TABLE 9 Europe Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2016 - 2019, USD Million
TABLE 10 Europe Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2020 - 2026, USD Million
TABLE 11 Europe Other Applications Market by Country, 2016 - 2019, USD Million
TABLE 12 Europe Other Applications Market by Country, 2020 - 2026, USD Million
TABLE 13 Europe Inhaled Nitric Oxide Market by Country, 2016 - 2019, USD Million
TABLE 14 Europe Inhaled Nitric Oxide Market by Country, 2020 - 2026, USD Million
TABLE 15 Germany Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 16 Germany Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 17 Germany Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 18 Germany Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 19 UK Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 20 UK Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 21 UK Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 22 UK Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 23 France Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 24 France Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 25 France Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 26 France Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 27 Russia Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 28 Russia Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 29 Russia Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 30 Russia Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 31 Spain Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 32 Spain Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 33 Spain Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 34 Spain Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 35 Italy Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 36 Italy Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 37 Italy Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 38 Italy Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 39 Rest of Europe Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 40 Rest of Europe Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 41 Rest of Europe Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 42 Rest of Europe Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 43 Key Information – Getinge AB
TABLE 44 key Information – Merck Group
TABLE 45 key Information – Halma PLC
TABLE 46 key Information – Linde PLC
TABLE 47 Key information – Air Liquide S.A.
TABLE 48 Key information – Beyond Air, Inc.
TABLE 49 Key information – Mallinckrodt PLC
TABLE 50 Key Information – VERO Biotech LLC
TABLE 51 key Information – Nu-Med Plus, Inc.
TABLE 52 key Information –Novoteris, LLC
List of Figures
FIG 1 Methodology for the research